The biotechnology R&D intensity in Denmark's business sector has witnessed significant fluctuations over the past decade. In 2023, it stood at 0.0066 Unit of Value Added in Industry. The sector experienced a sharp decrease from 2013 to 2021, with occasional upticks such as a notable 34.82% rise in 2022. However, the overall trend has been a decline, with a CAGR of -2.72% from 2018 to 2023. Forecasts for 2024-2028 predict a continued decline, with a forecast 5-year CAGR of -11.95% and an anticipated 47.08% reduction by 2028.
Future trends to watch for include advances in biotechnology that could potentially revive R&D intensity, governmental policy changes supporting biotech investments, and market dynamics such as increased private sector engagement or international collaborations. Close monitoring of technological breakthroughs and regulatory landscapes will be crucial for anticipating shifts in this trajectory.
